Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19726226 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
Conditions: Advanced Cancer;   Metastatic Cancer
Interventions: Drug: Nadroparin calcium;   Drug: saline solution (placebo)

Indicates status has not been verified in more than two years